Smith Margaret Ekinsinsider trades
In SEC Form 4 filings, Smith Margaret Ekins is listed as Chief Commercial Officer of ARS Pharmaceuticals, Inc. (SPRY). Smith Margaret Ekins reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 2.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| SPRYARS Pharmaceuticals, Inc. | Chief Commercial Officer | 1 | Sep 2 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-02
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.